Calcium EDTA: Clinical Trials

2 trials of Calcium EDTA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 1, Withdrawn 1
Phase 22Terminated 1, Withdrawn 1

Follow Calcium EDTA: new trials by email Literature Review of Calcium EDTA trials Research Report on Calcium EDTA

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
Calcium EDTA, Gd-DOTA - Renal Insufficiency, Chronic, Kidney Diseases
Phase 1 / Phase 2TerminatedAssistance Publique - Hôpitaux de Paris1662014-10-012018-05-18
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
Edetate Calcium Disodium, Ethanol, Trimethoprim-sulfamethoxazole - Chronic Myeloproliferative Disorders, Infection
Phase 1 / Phase 2WithdrawnM.D. Anderson Cancer Center2013-02-15

Conditions studied

Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Infections (1)  ·  Intraocular Lymphoma (1)  ·  Kidney Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Mast-Cell (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  M.D. Anderson Cancer Center (1)

Countries

France (1)

Top investigators

Jorge Cortes, MD (1)  ·  Marie Courbebaisse, Doctor (1)  ·  Patrick Chaftari, MD (1)